About DASHealth Dx

Kathryn E. Nuñez is a healthcare marketing and sales strategist with over 40 years of experience driving revenue growth and operational efficiency across diagnostics, biotech, and clinical lab services. At Dash Health, she leads marketing strategy, brand development, and customer journey optimization to support scalable growth across patient, practitioner, and lab segments. 

Prior to joining Dash, Kathryn held senior leadership roles at Hematogenix, Quest Diagnostics, and Ameripath, where she built high-performing sales teams, expanded international markets, and executed go-to-market strategies in oncology diagnostics, molecular testing, and companion diagnostics.

She has led multi-regional and global expansion efforts, including launching service delivery in Latin America and Asia, and managing multimillion-dollar territories for national and specialty labs.

With a background in biology and clinical laboratory science, Kathryn combines deep industry knowledge with a sharp eye for data-driven growth. Her experience spans complex stakeholder environments—from health systems and IDNs to niche specialty labs and concierge practitioners—positioning her as a key leader in Dash Health’s mission to transform mobile diagnostic care.

Nathan Cron is a mission-driven healthcare leader and industry pioneer dedicated to improving access to diagnostic care. As the founder and President of The National Phlebotomy Provider Network (NPPN)

Nathan has spent over 20 years building the nation's leading specimen collection network, bridging the gap between patients and critical diagnostic services.

His healthcare journey began in patient care, working with developmentally delayed and physically disabled individuals before serving as a medic in the Army National Guard. He later transitioned to clinical laboratory leadership, gaining experience at San Francisco General Hospital, UCSF, Hunter Laboratories, and CareDx. Nathan has also served as a specimen management consultant and research project manager for Aceris Research and has advised private CROs and university research teams at Stanford and UC Berkeley. His expertise in legal cases involving phlebotomy standards and best practices has been sought.

With a deep-rooted commitment to patient-centered care, Nathan has led NPPN’s growth into the premier provider of mobile phlebotomy services. His vision ensures that every patient receives the highest standard of care, just as he would want for his own family. Under his leadership, NPPN continues to expand its impact, setting new benchmarks for quality and accessibility in diagnostic healthcare.